VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Larimar Therapeutics, Inc. (LRMR) Total Return Calculator with Dividends Reinvested

Larimar Therapeutics, Inc.

Popular:

The total return for Larimar Therapeutics, Inc. (LRMR) stock is +84.33% over the past 12 months. So far it's up 15.27% this year. The 5-year total return is -71.14%, meaning $10,000 invested in LRMR stock 5 years ago would be worth $2,886 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in LRMR 1 year ago, it would be worth $18,433 today — you'd have gained $8,433.

With Dividends Reinvested$18,433+84.33%

Price Only (No DRIP)$18,433+84.33%

Period2025-05-07 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in LRMR

1Y$18,433+$8,433 (+84.3%)84.3% CAGR

3Y$8,299-$1,701 (-17.0%)-6.0% CAGR

5Y$2,886-$7,114 (-71.1%)-22.0% CAGR

10Y$523-$9,477 (-94.8%)-25.5% CAGR

15Y$169-$9,831 (-98.3%)-23.8% CAGR

20Y$169-$9,831 (-98.3%)-18.5% CAGR

30Y$169-$9,831 (-98.3%)-12.7% CAGR

Larimar Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading LRMR total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+15.27%	—	+15.27%	—	$11,527
1Y	+84.33%	84.33%	+84.33%	—	$18,433
3Y	-17.01%	-6.03%	-17.01%	—	$8,299
5Y	-71.14%	-22.01%	-71.14%	—	$2,886
10Y	-94.77%	-25.55%	-94.77%	—	$523
15Y	-98.31%	-23.82%	-98.31%	—	$169
20Y	-98.31%	-18.46%	-98.31%	—	$169
30Y	-98.31%	-12.72%	-98.31%	—	$169

Risk & Highlights

Best Year+60.74%2020

Worst Year-79.66%2015

Max Drawdown-44.90%2025-09-26 → 2026-02-23 · Recovered 2026-02-25

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+53.03%	+53.03%	—	+0.41%	+52.6pp
2025	-4.99%	-4.99%	—	+16.64%	-21.6pp
2024	-24.27%	-24.27%	—	+24.00%	-48.3pp
2023	+13.75%	+13.75%	—	+24.81%	-11.1pp
2022	-61.58%	-61.58%	—	-19.95%	-41.6pp

LRMR outperformed the S&P 500 by 53.96pp over the past year (+84.33% vs +30.37%).

Loading summary...

LRMR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
LRMRLarimar Therapeutics, Inc.	$342M	-20.6%	+15.3%	+84.3%	—	-17.0%	-71.1%	-94.8%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
PTCTPTC Therapeutics, Inc.	$5.3B	-7.3%	-16.0%	+58.2%	—	+16.1%	+60.3%	+733.2%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
AVNSAvanos Medical, Inc.	$1.2B	+80.9%	+121.6%	+96.9%	—	+5.6%	-39.8%	-17.0%
MNKDMannKind Corporation	$1.1B	+38.1%	-36.6%	-26.8%	—	-8.5%	-17.2%	-46.2%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
CRLCharles River Laboratories International, Inc.	$9.0B	+7.3%	-10.1%	+32.8%	—	-4.2%	-46.9%	+119.2%
IQVIQVIA Holdings Inc.	$30.3B	+4.7%	-20.7%	+16.5%	—	-5.9%	-23.8%	+166.5%

Compare:LRMR vs ACAD LRMR vs PRAX LRMR vs PTCT LRMR vs ACAD vs PRAX

About LRMR Dividend Returns

Larimar Therapeutics, Inc. (LRMR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of LRMR over the past year?

Larimar Therapeutics, Inc. (LRMR) delivered a return of 84.33% over the past year. Since LRMR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in LRMR be worth today?

A $10,000 investment in Larimar Therapeutics, Inc. one year ago would be worth $18,433 today, representing a gain of $8,433.

Q3Does LRMR pay dividends?

Larimar Therapeutics, Inc. (LRMR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LRMR, the total return equals the price-only return.

Q4Did LRMR beat the S&P 500?

Yes, Larimar Therapeutics, Inc. (LRMR) outperformed the S&P 500 by 53.96 percentage points over the past year. LRMR delivered a total return of 84.33%, compared to the S&P 500's 30.37%. This 53.96pp alpha means investors in LRMR earned more than a passive S&P 500 index fund.

Q5What is LRMR's worst drawdown?

Larimar Therapeutics, Inc. (LRMR) experienced a maximum drawdown of -44.90% over the past year, declining from its peak on 2025-09-26 to its trough on 2026-02-23. The stock recovered to its prior peak by 2026-02-25. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is LRMR's long-term total return over 10, 20, or 30 years?

Here are Larimar Therapeutics, Inc. (LRMR)'s long-term returns with dividends reinvested. Over 10 years, the total return is -94.8% (-25.5% CAGR) — $10,000 would have grown to $523. Over 20 years: -98.3% total return (-18.5% CAGR) — $10,000 → $169. Over 30 years: -98.3% total return (-12.7% CAGR) — $10,000 → $169. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was LRMR's best and worst year?

Larimar Therapeutics, Inc.'s best calendar year was 2020 with a total return of 60.7%. Its worst year was 2015 with a total return of -79.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 140.4 percentage points.